glp-1 drugs history The revolution: What UAB researchers are discovering about how these work Frontiers | GLP-1 receptor agonists:

10.1016/j.cmet.2010.03.014 64 KeH.LiF.DengW.LiZ.WangS.LvP.et al (2021)

Moran Eye Center at the University of Utah

Hamilton describes the method that Blevins and his colleagues used on rats: giving them GLP-1 drugs to reduce their appetite, and then giving them small doses of oxytocin, a hormone that can be used to reduce nausea

For those on GLP-1 medications, digestion may be slower, which means that the body may have difficulty properly processing food and absorbing nutrients

Kenya Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is valued at around $14.2 Mn in 2022 and is projected to reach $27.4 Mn by 2030, exhibiting a CAGR of 8.6% during the forecast period 2023-2030

This weight loss can greatly improve health, but eating much less food can sometimes lead to nutritional deficiencies, meaning your body isnt getting all the vitamins, minerals, or protein it needs